There are 2789 resources available
357P - A phase II study of anlotinib in the treatment of recurrent high-grade glioma
Presenter: Hui Dai
Session: ePoster Display
336TiP - Ipatasertib plus non-taxane chemotherapy for metastatic triple-negative breast cancer (TNBC): Pathfinder trial
Presenter: Antonio Llombart Cussac
Session: ePoster Display
337TiP - An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancer
Presenter: Debu Tripathy
Session: ePoster Display
361P - Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
Presenter: Alexandre Beige
Session: ePoster Display
339TiP - SOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Presenter: Luis Manso
Session: ePoster Display
364P - Implementation of a comprehensive streamlined next generation sequencing (NGS) test for glioma including detection of the 1p/19q codeletion
Presenter: Sian Wood
Session: ePoster Display
365P - The analysis of FGFR-gene family alterations in glioma
Presenter: yunqian Li
Session: ePoster Display
350P - Molecular profiling of tumor tissue and tumor-derived cell lines in patients with glioblastoma
Presenter: Tatiana Nasedkina
Session: ePoster Display
351P - Impact of time to initiation post-operative adjuvant chemo-radiation in glioblastoma multiform: A systematic review
Presenter: Sudibio Sudibio
Session: ePoster Display
368P - Characteristics of deleterious germline mutations in glioma patients
Presenter: Gousiyi Wang
Session: ePoster Display